“Start Quote

These results raise the possibility that a class of promising new cancer drugs may be effective at treating some pancreatic cancers”

End QuoteDr Julie SharpCancer Research UK

On/off

Studies in mice showed that a gene called USP9x, which normally stops a cell from dividing uncontrollably, is switched off in some pancreatic cancer cells.

The gene is not mutated, but other proteins and chemicals become stuck to it and turn the gene off.

Studies then showed that UPS9x was being turned off in human pancreatic cancer.

Prof David Tuveson, from the Cancer Research UK Cambridge Research Institute, said: "We suspected that the fault wasn't in the genetic code at all, but in the chemical tags on the surface of the DNA that switch genes on and off, and by running more lab tests we were able to confirm this.

"Drugs which strip away these tags are already showing promise in lung cancer and this study suggests they could also be effective."

Dr David Adams, from the Wellcome Trust Sanger Institute, said: "This study strengthens our emerging understanding that we must also look into the biology of cells to identify all the genes that play a role in cancer."

They argue that up to 15% of pancreatic cancers could be down the turning this one gene off.

Dr Julie Sharp, Cancer Research UK's senior science information manager, said: "These results raise the possibility that a class of promising new cancer drugs may be effective at treating some pancreatic cancers."

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.